methyl (R)-2-(4-chloro-3-(4-((2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methoxy)-2,6-dimethylbenzamido)phenyl)acetate | 1356963-69-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl (R)-2-(4-chloro-3-(4-((2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methoxy)-2,6-dimethylbenzamido)phenyl)acetate
• CAS: 1356963-69-3
• 化学式: C₂₇H₂₆ClNO₆
• 分子量: 495.96
• InChiKey: YBPVIAOXZQVEKA-HXUWFJFHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.14
• 重原子数：
  35.0
• 可旋转键数：
  7.0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  83.09
• 氢给体数：
  1.0
• 氢受体数：
  6.0

反应信息

• 作为反应物：
  描述：

  methyl (R)-2-(4-chloro-3-(4-((2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methoxy)-2,6-dimethylbenzamido)phenyl)acetate 在 sodium hydroxide 、 盐酸 作用下， 以 四氢呋喃 、 甲醇 、 水 为溶剂， 反应 2.0h， 以51%的产率得到[4-chloro-3-({4-[(2R)-2,3-dihydro-1,4-benzodioxin-2-ylmethoxy]-2,6-dimethylbenzoyl}amino)phenyl]acetic acid
  参考文献：
  名称：

  Discovery of new orally active prostaglandin D2 receptor antagonists

  摘要：

  To identify an orally available drug candidate, a series of 3-benzoylaminophenylacetic acids were synthesized and evaluated as prostaglandin D-2 (PGD(2)) receptor antagonists. Some of the compounds tested were found to exhibit excellent inhibitory activity against cAMP accumulation in human platelet rich plasma (hPRP), which is one of the indexes of DP antagonism. The optimization process including improvement of the physicochemical properties such as solubility, which may result in an improved pharmacokinetic (PK) profile, is presented. Optimized compounds were studied for their pharmacokinetics and in vivo potential. A structure-activity relationship study is also presented. Some of the test compounds were found to have in vivo efficacy towards the inhibition of PGD(2)-induced and OVA-induced vascular permeability in guinea pig conjunctiva. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.08.065
• 作为产物：
  描述：

  (R)-2-(羟基甲基)-1,4-苯并二噁烷 在 4-二甲氨基吡啶 、 caesium carbonate 、 三乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 生成 methyl (R)-2-(4-chloro-3-(4-((2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methoxy)-2,6-dimethylbenzamido)phenyl)acetate
  参考文献：
  名称：

  Discovery of new orally active prostaglandin D2 receptor antagonists

  摘要：

  To identify an orally available drug candidate, a series of 3-benzoylaminophenylacetic acids were synthesized and evaluated as prostaglandin D-2 (PGD(2)) receptor antagonists. Some of the compounds tested were found to exhibit excellent inhibitory activity against cAMP accumulation in human platelet rich plasma (hPRP), which is one of the indexes of DP antagonism. The optimization process including improvement of the physicochemical properties such as solubility, which may result in an improved pharmacokinetic (PK) profile, is presented. Optimized compounds were studied for their pharmacokinetics and in vivo potential. A structure-activity relationship study is also presented. Some of the test compounds were found to have in vivo efficacy towards the inhibition of PGD(2)-induced and OVA-induced vascular permeability in guinea pig conjunctiva. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.08.065